The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 4.5. It has been cited 259 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.834
From this paper's citation signal
Citation Network Contribution
3.7
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
NIDDK
Grant: DK112282
NIDDK
Grant: DK 71349
NIGMS
Grant: P30GM127211
NCATS
Grant: UL1TR001998
BLRD VA
Grant: I01 BX001984
NIDDK NIH HHS
Grant: R01 DK071349
BLRD VA
Grant: IS1 BX003153
NIDDK NIH HHS
Grant: R01 DK112282
NIH HHS
Grant: S10 OD021753
NCRR NIH HHS
Grant: P20 RR021954
CSRD VA
Grant: I01 CX001550
NHLBI NIH HHS
Grant: R01 HL120507
FWCI
17.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals